PT  - JOURNAL ARTICLE
AU  - Groenen, Karlijn H.J.
AU  - Jacobsen, Annika
AU  - Kersloot, Martijn G.
AU  - Vieira, Bruna
AU  - van Enckevort, Esther
AU  - Kaliyaperumal, Rajaram
AU  - Arts, Derk L.
AU  - ‘t Hoen, Peter A.C.
AU  - Cornet, Ronald
AU  - Roos, Marco
AU  - Kool, Leo Schultze
TI  - The de novo FAIRification process of a registry for vascular anomalies
AID  - 10.1101/2020.12.12.20245951
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.12.20245951
4099  - http://medrxiv.org/content/early/2020/12/14/2020.12.12.20245951.short
4100  - http://medrxiv.org/content/early/2020/12/14/2020.12.12.20245951.full
AB  - Background Patient data registries that are FAIR - Findable, Accessible, Interoperable, and Reusable for humans and computers - facilitate research across multiple resources. This is particularly relevant to rare diseases, where data often are scarce and scattered. Specific research questions can be asked across FAIR rare disease registries and other FAIR resources without physically combining the data.Results We successfully developed and implemented a process of making a rare disease registry for vascular anomalies FAIR from its conception - de novo. Here, we describe the five phases of this process in detail: i) pre-FAIRification, ii) facilitating FAIRification, iii) data collection, iv) generating FAIR data in real-time, and v) using FAIR data. This includes the creation of an electronic case report form and a semantic data model of the “Set of Common Data Elements for Rare Disease Registration” released by the European Commission, and the technical implementation in the Electronic Data Capture (EDC) system for real-time, automatic data FAIRification. Further, we describe how we contribute to the four facets of FAIR, and how our FAIRification process can be reused by other registries.Conclusions In conclusion, a detailed de novo FAIRification process of a registry for vascular anomalies is described. To a large extent, the process may be reused by other rare disease registries, and we envision this work to be a substantial contribution to an ecosystem of FAIR rare disease resources.Competing Interest StatementMK is employed by Castor, and DA is Castor's CEO. The remaining authors state no conflicts of interest.Funding StatementBV and LSK are members of the Vascular Anomalies Working Group (VASCA WG) of the European Reference Network for Rare Multisystemic Vascular Diseases (VASCERN) - Project ID: 769036. AJ, BV, EvE, RK, PAC'tH, RC and MR's work is supported by the funding from the European Union's Horizon 2020 research and innovation programme under the EJP RD COFUND-EJP N 825575. MK's and DA's work is supported by funding from Castor EDC. KG's work is supported by the department of Medical Imaging, Radboud University Medical Center. EvE is also supported by FAIR genomes, under ZonMW Personalized Medicine program N 846003201.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Radboud University Medical Center's Institutional Ethical Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe manuscript describes what parts or the workflow are available for reuse and where information/ data can be found.APIApplication Programming InterfaceBOYDs‘Bring your own data’ workshopsCC0Creative Common zeroCDEsSet of Common Data Elements for Rare Disease RegistrationsCSVComma Separated ValueDCATData Catalog VocabularyeCRFelectronic Case Report FormEDCElectronic Data Capture (platform)EHRElectronic Health RecordEJP RDEuropean Joint Programme on Rare DiseasesERDRIEuropean Rare Disease Registry InfrastructureERDRI.dorEuropean Rare Disease Registry Infrastructure – European Directory of RegistriesERDRI.mdrEuropean Rare Disease Registry Infrastructure – Metadata RepositoryERNEuropean Reference NetworkEUPIDEuropean Patient Identity ManagementFAIRFindable, Accessible, Interoperable, ReusableFDPFAIR Data PointHPOHuman Phenotype OntologyICDInternational Classification of DiseasesICFInformed Consent FormiCRF GeneratorInteroperable Case Report Forms GeneratorIRDiRCInternational Rare Disease Research ConsortiumISSVAInternational Society for the Study of Vascular AnomaliesJSONJavaScript Object NotationNCITNational Cancer Institute ThesaurusORDOOrphanet Ontology for Rare DiseaseOWLWeb Ontology LanguagePIFPatient Information FolderRDRare diseaseRDFResource Description FrameworkSPARQLSPARQL Protocol and RDF Query LanguageSNOMED CTSystematized Nomenclature of Medicine – Clinical TermsTSVTab Separated ValuesURLUniform Resource LocatorVASCAVascular AnomaliesVASCERNEuropean Reference Network on rare vascular diseasesW3CWorld Wide Web ConsortiumWHODASWHO Disability Assessment ScheduleXMLExtensible Markup Language